Global Vaccines For Children (VFC) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Vaccines For Children (VFC) Industry Forecast” looks at past sales and reviews total world Vaccines For Children (VFC) sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccines For Children (VFC) sales for 2023 through 2029. With Vaccines For Children (VFC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines For Children (VFC) industry.
This Insight Report provides a comprehensive analysis of the global Vaccines For Children (VFC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines For Children (VFC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccines For Children (VFC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines For Children (VFC) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines For Children (VFC).
The global Vaccines For Children (VFC) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccines For Children (VFC) players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines For Children (VFC) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Vaccines For Children (VFC) market?
What factors are driving Vaccines For Children (VFC) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines For Children (VFC) market opportunities vary by end market size?
How does Vaccines For Children (VFC) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Vaccines For Children (VFC) Industry Forecast” looks at past sales and reviews total world Vaccines For Children (VFC) sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccines For Children (VFC) sales for 2023 through 2029. With Vaccines For Children (VFC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines For Children (VFC) industry.
This Insight Report provides a comprehensive analysis of the global Vaccines For Children (VFC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines For Children (VFC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccines For Children (VFC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines For Children (VFC) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines For Children (VFC).
The global Vaccines For Children (VFC) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccines For Children (VFC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccines For Children (VFC) players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines For Children (VFC) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi
- Merck
- Pfizer
- Jintan
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
What is the 10-year outlook for the global Vaccines For Children (VFC) market?
What factors are driving Vaccines For Children (VFC) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines For Children (VFC) market opportunities vary by end market size?
How does Vaccines For Children (VFC) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines For Children (VFC) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccines For Children (VFC) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccines For Children (VFC) by Country/Region, 2018, 2022 & 2029
2.2 Vaccines For Children (VFC) Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines For Children (VFC) Sales by Type
2.3.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccines For Children (VFC) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccines For Children (VFC) Sale Price by Type (2018-2023)
2.4 Vaccines For Children (VFC) Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Vaccines For Children (VFC) Sales by Application
2.5.1 Global Vaccines For Children (VFC) Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccines For Children (VFC) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccines For Children (VFC) Sale Price by Application (2018-2023)
3 GLOBAL VACCINES FOR CHILDREN (VFC) BY COMPANY
3.1 Global Vaccines For Children (VFC) Breakdown Data by Company
3.1.1 Global Vaccines For Children (VFC) Annual Sales by Company (2018-2023)
3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Company (2018-2023)
3.2 Global Vaccines For Children (VFC) Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccines For Children (VFC) Revenue by Company (2018-2023)
3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Company (2018-2023)
3.3 Global Vaccines For Children (VFC) Sale Price by Company
3.4 Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines For Children (VFC) Product Location Distribution
3.4.2 Players Vaccines For Children (VFC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINES FOR CHILDREN (VFC) BY GEOGRAPHIC REGION
4.1 World Historic Vaccines For Children (VFC) Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccines For Children (VFC) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccines For Children (VFC) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccines For Children (VFC) Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccines For Children (VFC) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccines For Children (VFC) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccines For Children (VFC) Sales Growth
4.4 APAC Vaccines For Children (VFC) Sales Growth
4.5 Europe Vaccines For Children (VFC) Sales Growth
4.6 Middle East & Africa Vaccines For Children (VFC) Sales Growth
5 AMERICAS
5.1 Americas Vaccines For Children (VFC) Sales by Country
5.1.1 Americas Vaccines For Children (VFC) Sales by Country (2018-2023)
5.1.2 Americas Vaccines For Children (VFC) Revenue by Country (2018-2023)
5.2 Americas Vaccines For Children (VFC) Sales by Type
5.3 Americas Vaccines For Children (VFC) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines For Children (VFC) Sales by Region
6.1.1 APAC Vaccines For Children (VFC) Sales by Region (2018-2023)
6.1.2 APAC Vaccines For Children (VFC) Revenue by Region (2018-2023)
6.2 APAC Vaccines For Children (VFC) Sales by Type
6.3 APAC Vaccines For Children (VFC) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines For Children (VFC) by Country
7.1.1 Europe Vaccines For Children (VFC) Sales by Country (2018-2023)
7.1.2 Europe Vaccines For Children (VFC) Revenue by Country (2018-2023)
7.2 Europe Vaccines For Children (VFC) Sales by Type
7.3 Europe Vaccines For Children (VFC) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines For Children (VFC) by Country
8.1.1 Middle East & Africa Vaccines For Children (VFC) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccines For Children (VFC) Sales by Type
8.3 Middle East & Africa Vaccines For Children (VFC) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines For Children (VFC)
10.3 Manufacturing Process Analysis of Vaccines For Children (VFC)
10.4 Industry Chain Structure of Vaccines For Children (VFC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines For Children (VFC) Distributors
11.3 Vaccines For Children (VFC) Customer
12 WORLD FORECAST REVIEW FOR VACCINES FOR CHILDREN (VFC) BY GEOGRAPHIC REGION
12.1 Global Vaccines For Children (VFC) Market Size Forecast by Region
12.1.1 Global Vaccines For Children (VFC) Forecast by Region (2024-2029)
12.1.2 Global Vaccines For Children (VFC) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines For Children (VFC) Forecast by Type
12.7 Global Vaccines For Children (VFC) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines For Children (VFC) Product Portfolios and Specifications
13.1.3 GSK Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines For Children (VFC) Product Portfolios and Specifications
13.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines For Children (VFC) Product Portfolios and Specifications
13.3.3 Merck Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines For Children (VFC) Product Portfolios and Specifications
13.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Jintan
13.5.1 Jintan Company Information
13.5.2 Jintan Vaccines For Children (VFC) Product Portfolios and Specifications
13.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jintan Main Business Overview
13.5.5 Jintan Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines For Children (VFC) Product Portfolios and Specifications
13.6.3 CSL Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines For Children (VFC) Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines For Children (VFC) Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines For Children (VFC) Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines For Children (VFC) Product Portfolios and Specifications
13.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines For Children (VFC) Product Portfolios and Specifications
13.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines For Children (VFC) Product Portfolios and Specifications
13.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines For Children (VFC) Product Portfolios and Specifications
13.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines For Children (VFC) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccines For Children (VFC) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccines For Children (VFC) by Country/Region, 2018, 2022 & 2029
2.2 Vaccines For Children (VFC) Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines For Children (VFC) Sales by Type
2.3.1 Global Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccines For Children (VFC) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccines For Children (VFC) Sale Price by Type (2018-2023)
2.4 Vaccines For Children (VFC) Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Vaccines For Children (VFC) Sales by Application
2.5.1 Global Vaccines For Children (VFC) Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccines For Children (VFC) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccines For Children (VFC) Sale Price by Application (2018-2023)
3 GLOBAL VACCINES FOR CHILDREN (VFC) BY COMPANY
3.1 Global Vaccines For Children (VFC) Breakdown Data by Company
3.1.1 Global Vaccines For Children (VFC) Annual Sales by Company (2018-2023)
3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Company (2018-2023)
3.2 Global Vaccines For Children (VFC) Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccines For Children (VFC) Revenue by Company (2018-2023)
3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Company (2018-2023)
3.3 Global Vaccines For Children (VFC) Sale Price by Company
3.4 Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines For Children (VFC) Product Location Distribution
3.4.2 Players Vaccines For Children (VFC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINES FOR CHILDREN (VFC) BY GEOGRAPHIC REGION
4.1 World Historic Vaccines For Children (VFC) Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccines For Children (VFC) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccines For Children (VFC) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccines For Children (VFC) Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccines For Children (VFC) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccines For Children (VFC) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccines For Children (VFC) Sales Growth
4.4 APAC Vaccines For Children (VFC) Sales Growth
4.5 Europe Vaccines For Children (VFC) Sales Growth
4.6 Middle East & Africa Vaccines For Children (VFC) Sales Growth
5 AMERICAS
5.1 Americas Vaccines For Children (VFC) Sales by Country
5.1.1 Americas Vaccines For Children (VFC) Sales by Country (2018-2023)
5.1.2 Americas Vaccines For Children (VFC) Revenue by Country (2018-2023)
5.2 Americas Vaccines For Children (VFC) Sales by Type
5.3 Americas Vaccines For Children (VFC) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines For Children (VFC) Sales by Region
6.1.1 APAC Vaccines For Children (VFC) Sales by Region (2018-2023)
6.1.2 APAC Vaccines For Children (VFC) Revenue by Region (2018-2023)
6.2 APAC Vaccines For Children (VFC) Sales by Type
6.3 APAC Vaccines For Children (VFC) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines For Children (VFC) by Country
7.1.1 Europe Vaccines For Children (VFC) Sales by Country (2018-2023)
7.1.2 Europe Vaccines For Children (VFC) Revenue by Country (2018-2023)
7.2 Europe Vaccines For Children (VFC) Sales by Type
7.3 Europe Vaccines For Children (VFC) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines For Children (VFC) by Country
8.1.1 Middle East & Africa Vaccines For Children (VFC) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccines For Children (VFC) Sales by Type
8.3 Middle East & Africa Vaccines For Children (VFC) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines For Children (VFC)
10.3 Manufacturing Process Analysis of Vaccines For Children (VFC)
10.4 Industry Chain Structure of Vaccines For Children (VFC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines For Children (VFC) Distributors
11.3 Vaccines For Children (VFC) Customer
12 WORLD FORECAST REVIEW FOR VACCINES FOR CHILDREN (VFC) BY GEOGRAPHIC REGION
12.1 Global Vaccines For Children (VFC) Market Size Forecast by Region
12.1.1 Global Vaccines For Children (VFC) Forecast by Region (2024-2029)
12.1.2 Global Vaccines For Children (VFC) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines For Children (VFC) Forecast by Type
12.7 Global Vaccines For Children (VFC) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines For Children (VFC) Product Portfolios and Specifications
13.1.3 GSK Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines For Children (VFC) Product Portfolios and Specifications
13.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines For Children (VFC) Product Portfolios and Specifications
13.3.3 Merck Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines For Children (VFC) Product Portfolios and Specifications
13.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Jintan
13.5.1 Jintan Company Information
13.5.2 Jintan Vaccines For Children (VFC) Product Portfolios and Specifications
13.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jintan Main Business Overview
13.5.5 Jintan Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines For Children (VFC) Product Portfolios and Specifications
13.6.3 CSL Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines For Children (VFC) Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines For Children (VFC) Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines For Children (VFC) Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines For Children (VFC) Product Portfolios and Specifications
13.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines For Children (VFC) Product Portfolios and Specifications
13.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines For Children (VFC) Product Portfolios and Specifications
13.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines For Children (VFC) Product Portfolios and Specifications
13.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccines For Children (VFC) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccines For Children (VFC) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 8. Global Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Table 9. Global Vaccines For Children (VFC) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Vaccines For Children (VFC) Revenue Market Share by Type (2018-2023)
Table 11. Global Vaccines For Children (VFC) Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 13. Global Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Table 14. Global Vaccines For Children (VFC) Revenue by Application (2018-2023)
Table 15. Global Vaccines For Children (VFC) Revenue Market Share by Application (2018-2023)
Table 16. Global Vaccines For Children (VFC) Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Vaccines For Children (VFC) Sales by Company (2018-2023) & (K Doses)
Table 18. Global Vaccines For Children (VFC) Sales Market Share by Company (2018-2023)
Table 19. Global Vaccines For Children (VFC) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Vaccines For Children (VFC) Revenue Market Share by Company (2018-2023)
Table 21. Global Vaccines For Children (VFC) Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution and Sales Area
Table 23. Players Vaccines For Children (VFC) Products Offered
Table 24. Vaccines For Children (VFC) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines For Children (VFC) Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Vaccines For Children (VFC) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Vaccines For Children (VFC) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Vaccines For Children (VFC) Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Vaccines For Children (VFC) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Vaccines For Children (VFC) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Vaccines For Children (VFC) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 37. Americas Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 39. Americas Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Vaccines For Children (VFC) Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Vaccines For Children (VFC) Sales Market Share by Region (2018-2023)
Table 43. APAC Vaccines For Children (VFC) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Vaccines For Children (VFC) Revenue Market Share by Region (2018-2023)
Table 45. APAC Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 49. Europe Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 51. Europe Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines For Children (VFC)
Table 60. Key Market Challenges & Risks of Vaccines For Children (VFC)
Table 61. Key Industry Trends of Vaccines For Children (VFC)
Table 62. Vaccines For Children (VFC) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines For Children (VFC) Distributors List
Table 65. Vaccines For Children (VFC) Customer List
Table 66. Global Vaccines For Children (VFC) Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Vaccines For Children (VFC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Vaccines For Children (VFC) Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Vaccines For Children (VFC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Vaccines For Children (VFC) Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Vaccines For Children (VFC) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Vaccines For Children (VFC) Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Vaccines For Children (VFC) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GSK Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines For Children (VFC) Product Portfolios and Specifications
Table 82. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines For Children (VFC) Product Portfolios and Specifications
Table 87. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines For Children (VFC) Product Portfolios and Specifications
Table 92. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines For Children (VFC) Product Portfolios and Specifications
Table 97. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Jintan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 101. Jintan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 102. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Jintan Main Business
Table 104. Jintan Latest Developments
Table 105. CSL Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines For Children (VFC) Product Portfolios and Specifications
Table 107. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines For Children (VFC) Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines For Children (VFC) Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines For Children (VFC) Product Portfolios and Specifications
Table 122. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 127. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 132. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines For Children (VFC) Product Portfolios and Specifications
Table 137. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines For Children (VFC) Product Portfolios and Specifications
Table 142. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 1. Vaccines For Children (VFC) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccines For Children (VFC) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 8. Global Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Table 9. Global Vaccines For Children (VFC) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Vaccines For Children (VFC) Revenue Market Share by Type (2018-2023)
Table 11. Global Vaccines For Children (VFC) Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 13. Global Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Table 14. Global Vaccines For Children (VFC) Revenue by Application (2018-2023)
Table 15. Global Vaccines For Children (VFC) Revenue Market Share by Application (2018-2023)
Table 16. Global Vaccines For Children (VFC) Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Vaccines For Children (VFC) Sales by Company (2018-2023) & (K Doses)
Table 18. Global Vaccines For Children (VFC) Sales Market Share by Company (2018-2023)
Table 19. Global Vaccines For Children (VFC) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Vaccines For Children (VFC) Revenue Market Share by Company (2018-2023)
Table 21. Global Vaccines For Children (VFC) Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Vaccines For Children (VFC) Producing Area Distribution and Sales Area
Table 23. Players Vaccines For Children (VFC) Products Offered
Table 24. Vaccines For Children (VFC) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines For Children (VFC) Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Vaccines For Children (VFC) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Vaccines For Children (VFC) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Vaccines For Children (VFC) Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Vaccines For Children (VFC) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Vaccines For Children (VFC) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Vaccines For Children (VFC) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 37. Americas Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 39. Americas Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Vaccines For Children (VFC) Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Vaccines For Children (VFC) Sales Market Share by Region (2018-2023)
Table 43. APAC Vaccines For Children (VFC) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Vaccines For Children (VFC) Revenue Market Share by Region (2018-2023)
Table 45. APAC Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 49. Europe Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 51. Europe Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines For Children (VFC)
Table 60. Key Market Challenges & Risks of Vaccines For Children (VFC)
Table 61. Key Industry Trends of Vaccines For Children (VFC)
Table 62. Vaccines For Children (VFC) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines For Children (VFC) Distributors List
Table 65. Vaccines For Children (VFC) Customer List
Table 66. Global Vaccines For Children (VFC) Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Vaccines For Children (VFC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Vaccines For Children (VFC) Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Vaccines For Children (VFC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Vaccines For Children (VFC) Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Vaccines For Children (VFC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Vaccines For Children (VFC) Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Vaccines For Children (VFC) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Vaccines For Children (VFC) Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Vaccines For Children (VFC) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GSK Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines For Children (VFC) Product Portfolios and Specifications
Table 82. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines For Children (VFC) Product Portfolios and Specifications
Table 87. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines For Children (VFC) Product Portfolios and Specifications
Table 92. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines For Children (VFC) Product Portfolios and Specifications
Table 97. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Jintan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 101. Jintan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 102. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Jintan Main Business
Table 104. Jintan Latest Developments
Table 105. CSL Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines For Children (VFC) Product Portfolios and Specifications
Table 107. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines For Children (VFC) Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines For Children (VFC) Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines For Children (VFC) Product Portfolios and Specifications
Table 122. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 127. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines For Children (VFC) Product Portfolios and Specifications
Table 132. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines For Children (VFC) Product Portfolios and Specifications
Table 137. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines For Children (VFC) Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines For Children (VFC) Product Portfolios and Specifications
Table 142. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccines For Children (VFC)
Figure 2. Vaccines For Children (VFC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines For Children (VFC) Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Vaccines For Children (VFC) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccines For Children (VFC) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Vaccines For Children (VFC) Sales Market Share by Type in 2022
Figure 14. Global Vaccines For Children (VFC) Revenue Market Share by Type (2018-2023)
Figure 15. Vaccines For Children (VFC) Consumed in Government Institution
Figure 16. Global Vaccines For Children (VFC) Market: Government Institution (2018-2023) & (K Doses)
Figure 17. Vaccines For Children (VFC) Consumed in Private Sector
Figure 18. Global Vaccines For Children (VFC) Market: Private Sector (2018-2023) & (K Doses)
Figure 19. Vaccines For Children (VFC) Consumed in Other
Figure 20. Global Vaccines For Children (VFC) Market: Other (2018-2023) & (K Doses)
Figure 21. Global Vaccines For Children (VFC) Sales Market Share by Application (2022)
Figure 22. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2022
Figure 23. Vaccines For Children (VFC) Sales Market by Company in 2022 (K Doses)
Figure 24. Global Vaccines For Children (VFC) Sales Market Share by Company in 2022
Figure 25. Vaccines For Children (VFC) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Company in 2022
Figure 27. Global Vaccines For Children (VFC) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 30. Americas Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 32. APAC Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 34. Europe Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 39. Americas Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 40. Americas Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 41. United States Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Vaccines For Children (VFC) Sales Market Share by Region in 2022
Figure 46. APAC Vaccines For Children (VFC) Revenue Market Share by Regions in 2022
Figure 47. APAC Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 48. APAC Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 49. China Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 57. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 58. Europe Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 59. Europe Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 60. Germany Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Vaccines For Children (VFC) in 2022
Figure 75. Manufacturing Process Analysis of Vaccines For Children (VFC)
Figure 76. Industry Chain Structure of Vaccines For Children (VFC)
Figure 77. Channels of Distribution
Figure 78. Global Vaccines For Children (VFC) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Vaccines For Children (VFC)
Figure 2. Vaccines For Children (VFC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines For Children (VFC) Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Vaccines For Children (VFC) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccines For Children (VFC) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Vaccines For Children (VFC) Sales Market Share by Type in 2022
Figure 14. Global Vaccines For Children (VFC) Revenue Market Share by Type (2018-2023)
Figure 15. Vaccines For Children (VFC) Consumed in Government Institution
Figure 16. Global Vaccines For Children (VFC) Market: Government Institution (2018-2023) & (K Doses)
Figure 17. Vaccines For Children (VFC) Consumed in Private Sector
Figure 18. Global Vaccines For Children (VFC) Market: Private Sector (2018-2023) & (K Doses)
Figure 19. Vaccines For Children (VFC) Consumed in Other
Figure 20. Global Vaccines For Children (VFC) Market: Other (2018-2023) & (K Doses)
Figure 21. Global Vaccines For Children (VFC) Sales Market Share by Application (2022)
Figure 22. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2022
Figure 23. Vaccines For Children (VFC) Sales Market by Company in 2022 (K Doses)
Figure 24. Global Vaccines For Children (VFC) Sales Market Share by Company in 2022
Figure 25. Vaccines For Children (VFC) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Company in 2022
Figure 27. Global Vaccines For Children (VFC) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Vaccines For Children (VFC) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 30. Americas Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 32. APAC Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 34. Europe Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Vaccines For Children (VFC) Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Vaccines For Children (VFC) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 38. Americas Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 39. Americas Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 40. Americas Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 41. United States Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Vaccines For Children (VFC) Sales Market Share by Region in 2022
Figure 46. APAC Vaccines For Children (VFC) Revenue Market Share by Regions in 2022
Figure 47. APAC Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 48. APAC Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 49. China Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 57. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 58. Europe Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 59. Europe Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 60. Germany Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Vaccines For Children (VFC) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Vaccines For Children (VFC) in 2022
Figure 75. Manufacturing Process Analysis of Vaccines For Children (VFC)
Figure 76. Industry Chain Structure of Vaccines For Children (VFC)
Figure 77. Channels of Distribution
Figure 78. Global Vaccines For Children (VFC) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2024-2029)
